Terns Pharmaceuticals Inc...

3.51
-0.18 (-4.88%)
At close: Mar 03, 2025, 12:26 PM

Terns Pharmaceuticals Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 79.93M 143.24M 47.7M 74.85M 12.33M 82.52M
Short-Term Investments 183.51M 139.88M 118.28M n/a 7.32M 4.36M
Long-Term Investments n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 56K 37K 94K 246K 719K 335K
Receivables n/a n/a n/a 12.72M n/a n/a
Inventory n/a n/a n/a 2.97M n/a n/a
Other Current Assets 3.99M 2.07M 1.9M 3.3M 2.57M 1.59M
Total Current Assets 267.43M 285.19M 166.93M 90.87M 22.22M 88.48M
Property-Plant & Equipment 1.03M 1.8M 1.05M 1.18M 961K 261K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 1.08M 1.84M 1.14M 1.42M 1.68M 596K
Total Assets 268.52M 287.03M 168.07M 92.29M 23.9M 89.07M
Account Payables 2.52M 1.65M 2.13M 935K 1.64M 914K
Deferred Revenue n/a n/a n/a 836K n/a n/a
Short-Term Debt 603K 1.32M n/a 12.88M n/a n/a
Other Current Liabilities 7.62M 4.43M 3.91M 7.51M 3.31M 1.46M
Total Current Liabilities 11.94M 8.47M 6.82M 22.82M 4.95M 2.38M
Long-Term Debt n/a 544K n/a n/a n/a n/a
Other Long-Term Liabilities 1.21M 1.07M 947K 877K 14.4M 14.32M
Total Long-Term Liabilities 1.21M 1.61M 947K 877K 14.75M 14.47M
Total Liabilities 13.15M 10.08M 7.77M 23.7M 19.7M 16.84M
Total Debt 603K 1.21M n/a 12.88M n/a n/a
Common Stock 6K 5K 3K n/a n/a n/a
Retained Earnings -332.63M -242.42M -182.07M -131.91M -91.86M -23.25M
Comprehensive Income -19K -822K -338K -124K -106K 59K
Shareholders Equity 255.37M 276.94M 160.3M 68.59M 4.21M 72.23M
Total Investments 183.51M 139.88M 118.28M n/a 7.32M 4.36M